Company Encyclopedia
View More
name
Rapid Micro Biosystems
RPID.US
Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes growth direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides onsite technical training services.
768.31 B
RPID.USMarket value -Rank by Market Cap -/-

Financial Score

22/11/2025 Update
C
Life Sciences Tools and ServicesIndustry
Industry Ranking39/60
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreE
    • ROE-68.83%E
    • Profit Margin-145.11%E
    • Gross Margin8.88%E
  • Growth ScoreC
    • Revenue YoY16.63%B
    • Net Profit YoY8.48%C
    • Total Assets YoY-20.25%E
    • Net Assets YoY-47.46%E
  • Cash ScoreC
    • Cash Flow Margin-68.91%D
    • OCF YoY16.63%B
  • Operating ScoreD
    • Turnover0.32D
  • Debt ScoreC
    • Gearing Ratio47.48%C

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Dir Malloy Gifts 40,000 Of Rapid Micro Biosystems Inc [RPID]

    Malloy Kirk Director of Rapid Micro Biosystems Inc [RPID] filed a Form 4 on November 18, 2025 with the Securities and Exchange Commission disclosing the following changes in ownership:Date11/14/25TransactionGiftShares40,000Price$0.00ValueN/AEnding Holdings: 38,600 (28,600 - Direct, 10,000 - Indirect) For a free trial, or to learn more about our insider trading analysis and data services, please visit or contact us at (301) 913-5100 or send an email to info@washingtonservice.com.Founded in 1970, The Washington Service provides securities professionals with financial, economic and public policy research and data.

    Reuters·
    US
    RPID
    +2.71%
    Reuters·
    US
    RPID
    +2.71%

    Rapid Micro Biosystems (NASDAQ:RPID) Releases Earnings Results, Hits Expectations

    Rapid Micro Biosystems (NASDAQ:RPID) reported quarterly earnings of ($0.26) per share, meeting analysts' expectations. The company generated $7.84 million in revenue, surpassing the $7.60 million estimate. Despite a negative net margin of 145.63% and a return on equity of -63.07%, institutional investors have increased their stakes. Analysts have mixed ratings, with a consensus rating of "Moderate Buy" and a price target of $8.00. The stock traded at $3.10, reflecting a 12-month range of $0.87 to $4.50.

    Market Beat·
    US
    RPID
    +2.71%
    Market Beat·
    US
    RPID
    +2.71%

    Rapid Micro Biosystems | 10-Q: FY2025 Q3 Revenue Beats Estimate at USD 7.838 M

    LB filings·
    US
    RPID
    +2.71%
    LB filings·
    US
    RPID
    +2.71%

    Rapid Micro Biosystems Reports Third Quarter 2025 Financial Results; Announces Record Multi-System Customer Order and Raises Full-Year Revenue and System Placement Guidance

    LEXINGTON, Mass., Nov. 07, 2025 ( GLOBE NEWSWIRE ) -- Rapid Micro Biosystems, Inc. ( Nasdaq: RPID ) ( the "Company" ) , an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare ...

    GlobeNewswire·
    US
    RPID
    +2.71%
    GlobeNewswire·
    US
    RPID
    +2.71%

    Rapid Micro Biosystems | 8-K: FY2025 Q3 Revenue Beats Estimate at USD 7.838 M

    LB filings·
    US
    RPID
    +2.71%
    LB filings·
    US
    RPID
    +2.71%